Comparing Antipsychotic Drug Compliance in Adult Patients with Schizophrenia Spectrum Disorders Receiving Long-acting Injectable versus Oral Medications (0.17h)

This educational offering provides 0.17 CEU and was presented in the Clinical track. The course includes a static poster and an MP4 video file from the presentation originally shared at the 14th National Doctors of Nursing Practice Conference at the Swissotel in Chicago, August 2021.

Caroline Lukano, DNP, PMHNP-BC, FNP-BC
Caroline Lukano is a dual-certified psychiatric nurse practitioner and family nurse practitioner for over five years. She worked as a registered nurse for more than eight years prior to becoming a nurse practitioner. She works full-time in psychiatry at a community mental health clinic. She holds a master’s degree from Troy University as a Family Nurse Practitioner and a Post Masters Certificate in Psychiatric Mental Health Nurse Practitioner from John Hopkins. Caroline is currently finishing her Doctor of Nursing Practice at Troy University with tentative graduation in spring 2021.

Purpose
The purpose of this presentation was to determine whether long-acting injectable (LAI) or oral antipsychotic medications were more effective in achieving compliance among patients with schizophrenia spectrum disorders. The goal of this presentation is to educate the importance for mental health clinicians to identify barriers related to medication compliance which are multifaceted. Another goal is to highlight the need for mental health clinicians to use multifactorial strategies by applying a multidisciplinary approach to improve medication compliance among patients with schizophrenia spectrum disorder receiving antipsychotic medications.